- Home
- WHG vs PRQR Comparison
WHG vs PRQR Comparison
Compare WHG & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHG
- PRQR
- Stock Information
- Founded
- WHG 1983
- PRQR 2012
- Country
- WHG United States
- PRQR Netherlands
- Employees
- WHG N/A
- PRQR N/A
- Industry
- WHG Investment Managers
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- WHG Finance
- PRQR Health Care
- Exchange
- WHG Nasdaq
- PRQR Nasdaq
- Market Cap
- WHG 146.3M
- PRQR 163.3M
- IPO Year
- WHG 2002
- PRQR 2014
- Fundamental
- Price
- WHG $14.56
- PRQR $1.78
- Analyst Decision
- WHG
- PRQR Strong Buy
- Analyst Count
- WHG 0
- PRQR 7
- Target Price
- WHG N/A
- PRQR $9.00
- AVG Volume (30 Days)
- WHG 16.5K
- PRQR 407.0K
- Earning Date
- WHG 04-30-2025
- PRQR 05-08-2025
- Dividend Yield
- WHG 4.06%
- PRQR N/A
- EPS Growth
- WHG N/A
- PRQR N/A
- EPS
- WHG 0.04
- PRQR N/A
- Revenue
- WHG $95,241,000.00
- PRQR $21,212,711.00
- Revenue This Year
- WHG N/A
- PRQR $2.87
- Revenue Next Year
- WHG N/A
- PRQR N/A
- P/E Ratio
- WHG $309.53
- PRQR N/A
- Revenue Growth
- WHG 6.08
- PRQR 85.91
- 52 Week Low
- WHG $11.11
- PRQR $1.07
- 52 Week High
- WHG $18.03
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- WHG 38.75
- PRQR 58.87
- Support Level
- WHG $14.78
- PRQR $1.65
- Resistance Level
- WHG $15.46
- PRQR $1.83
- Average True Range (ATR)
- WHG 0.43
- PRQR 0.11
- MACD
- WHG -0.02
- PRQR 0.00
- Stochastic Oscillator
- WHG 4.72
- PRQR 84.85
About WHG Westwood Holdings Group Inc
Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.